Skip to main content
. Author manuscript; available in PMC: 2026 Apr 28.
Published in final edited form as: Eur J Med Chem. 2025 Jul 8;297:117960. doi: 10.1016/j.ejmech.2025.117960

Figure 2. Ligand-based pharmacophore model used for virtual screening.

Figure 2.

(a) E-pharmacophore hypothesis with key pharmacophoric features (AHHHHRR). (b) Receiver operating characteristic (ROC) curve analysis evaluating the predictive performance of the ligand-based pharmacophore model.